These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 28219961)

  • 1. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes.
    Thorlacius L; Ingram JR; Garg A; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Christensen R; Jemec GB
    BMJ Open; 2017 Feb; 7(2):e014733. PubMed ID: 28219961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.
    Thorlacius L; Ingram JR; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Nielsen SM; Christensen R; Garg A; Jemec GBE;
    Br J Dermatol; 2018 Sep; 179(3):642-650. PubMed ID: 29654696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II.
    Thorlacius L; Garg A; Ingram JR; Villumsen B; Theut Riis P; Gottlieb AB; Merola JF; Dellavalle R; Ardon C; Baba R; Bechara FG; Cohen AD; Daham N; Davis M; Emtestam L; Fernández-Peñas P; Filippelli M; Gibbons A; Grant T; Guilbault S; Gulliver S; Harris C; Harvent C; Houston K; Kirby JS; Matusiak L; Mehdizadeh A; Mojica T; Okun M; Orgill D; Pallack L; Parks-Miller A; Prens EP; Randell S; Rogers C; Rosen CF; Choon SE; van der Zee HH; Christensen R; Jemec GBE
    Br J Dermatol; 2018 Mar; 178(3):715-721. PubMed ID: 29080368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Handover Core Outcome Measures (SH-CORE): a protocol for the development of a core outcome set for trials in surgical handover.
    Ryan JM; Devane D; Simiceva A; Eppich W; Kavanagh DO; Cullen C; Hogan AM; McNamara DA
    Trials; 2024 Jun; 25(1):373. PubMed ID: 38858749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Core Outcome Set for Studies on Obesity in Pregnant Patients (COSSOPP): a study protocol.
    Dadouch R; Faheim M; Juando-Prats C; Parsons J; D'Souza R;
    Trials; 2018 Nov; 19(1):655. PubMed ID: 30482249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
    Wainman HE; Chandran NS; Frew JW; Garg A; Gibbons A; Gierbolini A; Horvath B; Jemec GB; Kirby B; Kirby J; Lowes MA; Martorell A; McGrath BM; Naik HB; Oon HH; Prens E; Sayed CJ; Thorlacius L; Van der Zee HH; Villumsen B; Ingram JR
    Br J Dermatol; 2024 Mar; 190(4):510-518. PubMed ID: 37976235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
    Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
    BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol.
    Carey B; Farag AM; Nasri-Heir C; Klasser GD; Ariyawardana A; Chmieliauskaite M; Sardella A; Carlson CR; Miller CS; Mejia L; O'Neill FE; Albuquerque R
    Trials; 2020 Aug; 21(1):711. PubMed ID: 32787910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing a core outcome set on traditional Chinese medicine (COS-TCM) for chronic heart failure (CHF): a study protocol.
    Zhang M; Chua HZ; Zhang J; Niu B; Zheng W; Li K; Zhang B
    BMJ Open; 2021 Jul; 11(7):e047148. PubMed ID: 34215606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Ma C; Panaccione R; Fedorak RN; Parker CE; Khanna R; Levesque BG; Sandborn WJ; Feagan BG; Jairath V
    BMJ Open; 2017 Jun; 7(6):e016146. PubMed ID: 28601837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.
    Harman NL; Wilding J; Curry D; Harris J; Logue J; Pemberton RJ; Perreault L; Thompson G; Tunis S; Williamson PR;
    Trials; 2018 Aug; 19(1):427. PubMed ID: 30086771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement.
    Mastacouris N; Tannenbaum R; Strunk A; Koptyev J; Aarts P; Alhusayen R; Bechara FG; Benhadou F; Bettoli V; Brassard A; Brown D; Choon SE; Coutts P; da Silva DLF; Daveluy S; Dellavalle RP; Del Marmol V; Emtestam L; Gebauer K; George R; Giamarellos-Bourboulis EJ; Goldfarb N; Hamzavi I; Hazen PG; Horváth B; Hsiao J; Ingram JR; Jemec GBE; Kirby JS; Lowes MA; Marzano AV; Matusiak L; Naik HB; Okun MM; Oon HH; Orenstein LAV; Paek SY; Pascual JC; Fernandez-Peñas P; Resnik BI; Sayed CJ; Thorlacius L; van der Zee HH; van Straalen KR; Garg A
    JAMA Dermatol; 2023 Nov; 159(11):1258-1266. PubMed ID: 37755725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an international core outcome set for treatment trials in necrotizing enterocolitis-a study protocol.
    Klerk DH; van Varsseveld OC; Offringa M; Modi N; Lacher M; Zani A; Pakarinen MP; Koivusalo A; Jester I; Spruce M; Derikx JPM; Bakx R; Ksia A; Vermeulen MJ; Kooi EMW; Hulscher JBF
    Trials; 2023 May; 24(1):367. PubMed ID: 37259112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core outcome research measures in anal cancer (CORMAC): protocol for systematic review, qualitative interviews and Delphi survey to develop a core outcome set in anal cancer.
    Fish R; Sanders C; Williamson PR; Renehan AG
    BMJ Open; 2017 Nov; 7(11):e018726. PubMed ID: 29170292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of reporting guidance and core outcome sets for seamless, standardised evaluation of innovative surgical procedures and devices: a study protocol for content generation and a Delphi consensus process (COHESIVE study).
    Avery K; Blazeby J; Wilson N; Macefield R; Cousins S; Main B; Blencowe NS; Zahra J; Elliott D; Hinchliffe R; Potter S
    BMJ Open; 2019 Sep; 9(9):e029574. PubMed ID: 31515426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis.
    Tallouzi MO; Mathers JM; Moore DJ; Murray PI; Bucknall N; Blazeby JM; Calvert M; Denniston AK
    Trials; 2017 Dec; 18(1):576. PubMed ID: 29191216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an international core outcome set for treatment trials in paediatric inguinal hernia: protocol for a three-phase study including a systematic review and Delphi survey.
    Maat SC; Gorter RR; van Heurn ELW; Rippen H; Butcher NJ; Offringa M; Derikx JPM
    BMJ Open; 2023 Dec; 13(12):e077452. PubMed ID: 38097238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Core outcome set for fetal Myelomeningocele (COSMiC): study protocol.
    Altoukhi S; Whitehead CL; Ryan G; Deprest J; Joyeux L; Gallagher K; Drake J; Church P; Horn D; Diambomba Y; Carvalho JCA; Van Mieghem T
    Trials; 2020 Aug; 21(1):732. PubMed ID: 32825852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.